The vaccine is approved as a 3-dose series, which consists of a 0.5 mL intramuscular injection, administered at 2, 4, and 6 months of age.
Colleen Hall
Advertisement
Articles by Colleen Hall
Advertisement
Latest Updated Articles
Pediatric Hexavalent Combination Vaccine Approved by FDAPublished: December 28th 2018 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Cefiderocol is Noninferior, But not "Game-Changer," for Gram-negative Bloodstream Infections
2
As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link
3
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
4
Emerging Diagnostic Tools and Mycobacterial Challenges in Skin and Soft Tissue Infections
5
